Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Analytical and Bioanalytical Chemistry
|
March 16, 2007
Practical evaluation of universal conditions for four-plex quantitative PCR
Tsuyoshi Ishii, Hiroshi Sootome, Keizo Yamashita
Analytical Biochemistry
|
January 30, 2007
Validation of universal conditions for duplex quantitative reverse transcription polymerase chain reaction assays
Tsuyoshi Ishii, Hiroshi Sootome, Lihua Shan, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|
October 9, 2024
[Pharmacological characteristics and clinical effectiveness of Futibatinib (Lytgobi<sub>®</sub> Tablets), a covalently-binding, irreversible FGFR1-4 inhibitor]
Katsuya Takagaki, Ryota Okude, Naoki Hirayama, et al.
Cancer Science
|
April 1, 2025
Pimitespib, an HSP90 Inhibitor, Enhances the Efficacy of PARP Inhibitors in PARP Inhibitor-Insensitive Breast Cancer Cells
Hiromi Muraoka, Hiromi Kazuno, Akihiro Hashimoto, et al.
Molecular Cancer Therapeutics
|
August 14, 2020
Aurora A Inhibitor TAS-119 Enhances Antitumor Efficacy of Taxanes <i>In Vitro</i> and <i>In Vivo</i>: Preclinical Studies as Guidance for Clinical Development and Trial Design
Hiroshi Sootome, Akihiro Miura, Norio Masuko, et al.
Assay and Drug Development Technologies
|
September 5, 2007
Dual enzyme-linked immunosorbent assay system for detection of endogenous kinase activities of mitogen- and stress-activated protein kinase-1/2
Tsuyoshi Ishii, Hiroshi Sootome, Hiroko Toyoda, et al.
Journal of Biomolecular Screening
|
May 23, 2007
A selective cellular screening assay for B-Raf and c-Raf kinases
Tsuyoshi Ish, Hiroshi Sootome, Yukiko Yagi, et al.
Journal of Biomolecular Screening
|
May 23, 2007
A robust, target-driven, cell-based assay for checkpoint kinase 1 inhibitors
Tsuyoshi Ish, Hiroshi Sootome, Alastair J King, et al.
Analytical and Bioanalytical Chemistry
|
November 7, 2007
A cell-based screening method for specifically detecting kinase activity
Mikiya Suda, Tsuyoshi Ishii, Hiroshi Sootome, et al.
Molecular Cancer Therapeutics
|
June 24, 2010
MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo
Hiroshi Hirai, Hiroshi Sootome, Yoko Nakatsuru, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Analytical and Bioanalytical Chemistry
|
March 16, 2007
Practical evaluation of universal conditions for four-plex quantitative PCR
Tsuyoshi Ishii, Hiroshi Sootome, Keizo Yamashita
Analytical Biochemistry
|
January 30, 2007
Validation of universal conditions for duplex quantitative reverse transcription polymerase chain reaction assays
Tsuyoshi Ishii, Hiroshi Sootome, Lihua Shan, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|
October 9, 2024
[Pharmacological characteristics and clinical effectiveness of Futibatinib (Lytgobi<sub>®</sub> Tablets), a covalently-binding, irreversible FGFR1-4 inhibitor]
Katsuya Takagaki, Ryota Okude, Naoki Hirayama, et al.
Cancer Science
|
April 1, 2025
Pimitespib, an HSP90 Inhibitor, Enhances the Efficacy of PARP Inhibitors in PARP Inhibitor-Insensitive Breast Cancer Cells
Hiromi Muraoka, Hiromi Kazuno, Akihiro Hashimoto, et al.
Molecular Cancer Therapeutics
|
August 14, 2020
Aurora A Inhibitor TAS-119 Enhances Antitumor Efficacy of Taxanes <i>In Vitro</i> and <i>In Vivo</i>: Preclinical Studies as Guidance for Clinical Development and Trial Design
Hiroshi Sootome, Akihiro Miura, Norio Masuko, et al.
Assay and Drug Development Technologies
|
September 5, 2007
Dual enzyme-linked immunosorbent assay system for detection of endogenous kinase activities of mitogen- and stress-activated protein kinase-1/2
Tsuyoshi Ishii, Hiroshi Sootome, Hiroko Toyoda, et al.
Journal of Biomolecular Screening
|
May 23, 2007
A selective cellular screening assay for B-Raf and c-Raf kinases
Tsuyoshi Ish, Hiroshi Sootome, Yukiko Yagi, et al.
Journal of Biomolecular Screening
|
May 23, 2007
A robust, target-driven, cell-based assay for checkpoint kinase 1 inhibitors
Tsuyoshi Ish, Hiroshi Sootome, Alastair J King, et al.
Analytical and Bioanalytical Chemistry
|
November 7, 2007
A cell-based screening method for specifically detecting kinase activity
Mikiya Suda, Tsuyoshi Ishii, Hiroshi Sootome, et al.
Molecular Cancer Therapeutics
|
June 24, 2010
MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo
Hiroshi Hirai, Hiroshi Sootome, Yoko Nakatsuru, et al.
Page
of 2